125 related articles for article (PubMed ID: 37209901)
1. Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma.
Goda C; Kolovich S; Rudich A; Karunasiri M; Kulkarni R; Rajgolikar G; Neidemire-Colley L; Singh S; Sircar A; Ranganathan P; Garzon R; Sehgal L; Dorrance AM
Exp Hematol; 2023 Jul; 123():28-33.e3. PubMed ID: 37209901
[TBL] [Abstract][Full Text] [Related]
2. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia.
Bill M; Pathmanathan A; Karunasiri M; Shen C; Burke MH; Ranganathan P; Papaioannou D; Zitzer NC; Snyder K; LaRocco A; Walker AE; Brannan ZJ; Nalin AP; Freud AG; Dikov MM; Zhang X; Bloomfield CD; Garzon R; Dorrance AM
Clin Cancer Res; 2020 Feb; 26(3):669-678. PubMed ID: 31672772
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.
Papaioannou D; Shen C; Nicolet D; McNeil B; Bill M; Karunasiri M; Burke MH; Ozer HG; Yilmaz SA; Zitzer N; Behbehani GK; Oakes CC; Steiner DJ; Marcucci G; Powell BL; Kolitz JE; Carter TH; Wang ES; Mrózek K; Croce CM; Caligiuri MA; Bloomfield CD; Garzon R; Dorrance AM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4641-E4647. PubMed ID: 28533390
[TBL] [Abstract][Full Text] [Related]
4. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
6. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
7. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
[TBL] [Abstract][Full Text] [Related]
8. Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.
Mastorci K; Muraro E; Pasini E; Furlan C; Sigalotti L; Cinco M; Dolcetti R; Fratta E
PLoS One; 2016; 11(4):e0153823. PubMed ID: 27123851
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.
Wang L; Zhao Y; Qian J; Sun L; Lu Y; Li H; Li Y; Yang J; Cai Z; Yi Q
Cancer; 2013 Feb; 119(4):782-91. PubMed ID: 22915070
[TBL] [Abstract][Full Text] [Related]
10. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.
Wu F; Yang LY; Li YF; Ou DP; Chen DP; Fan C
Hepatology; 2009 Dec; 50(6):1839-50. PubMed ID: 19824075
[TBL] [Abstract][Full Text] [Related]
11. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
[TBL] [Abstract][Full Text] [Related]
12. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
[TBL] [Abstract][Full Text] [Related]
13. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
Usuba R; Pauty J; Soncin F; Matsunaga YT
Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
[TBL] [Abstract][Full Text] [Related]
14. EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades.
Chim SM; Kuek V; Chow ST; Lim BS; Tickner J; Zhao J; Chung R; Su YW; Zhang G; Erber W; Xian CJ; Rosen V; Xu J
J Cell Physiol; 2015 Jan; 230(1):82-94. PubMed ID: 24909139
[TBL] [Abstract][Full Text] [Related]
15. The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.
Lu K; Chen N; Zhou XX; Ge XL; Feng LL; Li PP; Li XY; Geng LY; Wang X
Biochem Biophys Res Commun; 2015 Aug; 464(1):292-8. PubMed ID: 26116769
[TBL] [Abstract][Full Text] [Related]
16. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
[TBL] [Abstract][Full Text] [Related]
17. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
[TBL] [Abstract][Full Text] [Related]
18. Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia.
Lacko LA; Massimiani M; Sones JL; Hurtado R; Salvi S; Ferrazzani S; Davisson RL; Campagnolo L; Stuhlmann H
Mech Dev; 2014 Aug; 133():163-76. PubMed ID: 24751645
[TBL] [Abstract][Full Text] [Related]
19. Proteomics identifies EGF-like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor-positive glioma.
Wang FY; Wang-Gou SY; Cao H; Jiang N; Yang Q; Huang Q; Huang CH; Li XJ
Cancer Commun (Lond); 2020 Oct; 40(10):518-530. PubMed ID: 32888253
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]